Investor Kent Lake Capital LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Kent Lake Capital LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-08-08 13G/A RGS / Regis Corporation 111,500
2024-08-08 13G RGS / Regis Corporation 120,000
2024-06-28 13G UEIC / Universal Electronics Inc. 647,304
2024-06-28 13G STIM / Neuronetics, Inc. 1,116,041 1,500,000
2024-05-16 13D MDRX / Veradigm Inc. 6,000,000 5,385,000
2024-05-10 13G SILC / Silicom Ltd. 315,000
2024-03-12 13G MDRX / Veradigm Inc. 6,000,000
2024-02-15 13G/A VAPO / Vapotherm, Inc. 316,368 499,619
2024-02-14 13G/A STIM / Neuronetics, Inc. 1,600,100 1,116,041
2024-02-14 13G/A ZIMV / ZimVie Inc. 1,340,655 1,000,000
2023-11-02 13G VAPO / Vapotherm, Inc. 316,368
2023-09-22 13G STIM / Neuronetics, Inc. 0 1,600,100
2023-04-20 13G ZIMV / ZimVie Inc. 1,340,655
2022-02-14 13G/A STIM / Neuronetics, Inc. 1,242,000 0
2021-02-16 13G/A SSKN / STRATA Skin Sciences, Inc. 2,701,788 1,658,043
2021-02-16 13G/A SSKN / STRATA Skin Sciences, Inc. 1,658,043 1,658,043
2021-02-12 13G/A STIM / Neuronetics, Inc. 952,000 1,242,000
2020-08-14 13G STIM / Neuronetics, Inc. 952,000
2020-02-14 13G/A SSKN / STRATA Skin Sciences, Inc. 2,042,321 2,701,788
2019-06-28 13G SSKN / STRATA Skin Sciences, Inc. 2,042,321